Evidence map›Paper›PMID 30022875›Full record

ArticleExperimental neurobiology2018

Leucine-rich G Protein-coupled Receptor-5 Is Significantly Increased in the Aqueous Humor of Human Eye with Proliferative Diabetic Retinopathy.

Eun Hee Hong, Mina Hwang, Yong Un Shin, Hyun-Hee Park, Seong-Ho Koh, Heeyoon Cho

Abstract read
In one paragraph

Article in Experimental neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Eun Hee HongDepartment of Ophthalmology, Hanyang University College of Medicine, Seoul 04763, Korea.
Mina HwangDepartment of Neurology, Hanyang University College of Medicine, Seoul 04763, Korea.
Yong Un ShinDepartment of Ophthalmology, Hanyang University College of Medicine, Seoul 04763, Korea.
Hyun-Hee ParkDepartment of Neurology, Hanyang University College of Medicine, Seoul 04763, Korea.
Seong-Ho KohDepartment of Neurology, Hanyang University College of Medicine, Seoul 04763, Korea.
Heeyoon ChoDepartment of Ophthalmology, Hanyang University College of Medicine, Seoul 04763, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leucine-rich G protein-coupled receptor-5 (LGR5) is known to be a stem cell marker in many organs. LGR5 may have important roles in proliferative diabetic retinopathy (PDR) because LGR5 potentiate the Wnt/β-catenin pathway, which plays crucial roles in pathologic neovascularization in the retina. The association between LGR5 and retinal pathologic neovascularization has not yet been reported. In the present study, LGR5 was compared in human aqueous humor (AH) between normal control and patients with PDR to confirm the relationship between LGR5 and PDR. AH was collected from 7 naïve PDR patients and 3 control subjects before intravitreal injection and cataract surgery, respectively. LGR5 and key members of Wnt/β-catenin were assessed by western blotting. In the present study, it was confirmed for the first time that LGR5 is detected in AH and it increases in PDR patients. Key members of Wnt/β-catenin pathway were also increased in AH of PDR patients compared to control. These findings might support the hypothesis that LGR5 has important roles in PDR especially considering the roles of the Wnt/β-catenin pathway, which is activated by LGR5, contributing to retinal pathologic neovascularization.

Indexed as

Aqueous humorDiabetic retinopathyLeucine-rich G protein-coupled receptor-5Pathologic neovascularizationWnt signaling pathway

Identifiers

PMID30022875
PMCPMC6050418

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.